Are weight loss injections safe? The NHS evidence, risks and what to watch for

Step 1: clinical assessment before anything is prescribed

The process starts well before a pen arrives on your doorstep. A GPhC-registered Independent Prescriber reviews your medical history, current medicines, weight and relevant conditions. That review exists because these are not straightforward over-the-counter products, their safety profile is well-established when used appropriately, and that word 'appropriately' does a lot of work.

One misconception worth laying to rest gently: many people assume weight loss injections are riskier than they are, having read alarming headlines alongside claims that they are handed out freely online. If you have been wondering whether weight loss injections are safe and what the NHS position is, the reality is more nuanced than the headlines suggest. Clinical trial programmes involving thousands of adults showed that serious adverse events were uncommon, while mild-to-moderate gastrointestinal effects were expected and manageable. NICE's appraisal of tirzepatide (TA1026) reviewed that evidence in full before recommending the medicine. The risk is not zero; it is knowable and manageable with the right oversight.

At nume, every new patient completes a structured consultation reviewed personally by a prescriber on the same day. Photo-ID and live weight verification are part of that process, not afterthoughts. Our prescribers discuss suitability and side effects as part of every consultation, you can start your free consultation here.

Step 2: what normal side effects look like, and when they ease

The most commonly reported effects are digestive: nausea, vomiting, diarrhoea, constipation, reflux and burping. Fatigue and mild headache appear in some people, particularly after starting or after a dose increase. These are real and can be uncomfortable, but the pattern seen in trials (and in prescribing practice since) is that they peak in the first one to two weeks of a new dose and then settle.

Staying hydrated matters. Eating smaller portions, avoiding fatty or very rich food and not lying down immediately after eating all reduce the likelihood of nausea. Your prescriber and the Patient Information Leaflet that comes with your pen cover this in detail; the NHS tirzepatide medicines page also summarises the key practical points.

Injection-site reactions (mild redness or tenderness at the site) are possible and usually resolve quickly. Rotating injection sites between the abdomen, thigh and upper arm helps avoid this. For a closer look at how a supervised clinic manages these considerations day to day, the Coach House Clinic's approach to weight loss injections is a useful point of reference. None of these common effects are reasons to stop without speaking to a prescriber first.

Step 3: recognising side effects that need urgent medical attention

Most side effects are self-limiting, but some require prompt action. The MHRA's January 2026 Drug Safety Update highlighted acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines. The symptom to act on is severe stomach pain that does not go away and may spread to your back, with or without vomiting. If that happens, stop the injection and seek emergency care, do not wait to see if it passes.

Other situations that need the same prompt response: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat), symptoms of gallbladder problems (severe pain in the upper right abdomen, particularly after eating), and any signs of significant dehydration following repeated vomiting or diarrhoea (dizziness, very dark urine, inability to keep fluids down).

Suspected side effects can and should be reported at the MHRA's Yellow Card scheme, this is how the regulator tracks real-world safety signals after medicines reach patients. If you are a nume patient and have concerns between doses, our aftercare team is available seven days a week. You can also reach us via our contact page.

Step 4: the supply chain matters as much as the medicine itself

Licensed, clinically supervised treatment through a GPhC-registered pharmacy is a different category of thing from buying a pen through a social media ad or an unverified website. The MHRA has warned repeatedly about counterfeit weight loss pens, some seized products have contained insulin rather than the labelled medicine, with the potential for serious harm. Roughly 20 million doses of illegally traded weight loss medicines, with a street value around £45 million, were seized in enforcement operations in 2025 alone.

The simple check: any online pharmacy dispensing prescription medicines in the UK must be on the GPhC register. If it is not there, or if a seller is offering these medicines without any clinical assessment, those are clear warning signs. Verifying a pharmacy takes about thirty seconds and removes a lot of uncertainty.

Questions about whether weight loss injections are safe and how the NHS approaches them are something patients frequently ask before starting treatment, and it is worth reading the detail rather than relying on headlines. More on what weight loss injections are available through the NHS and how that route works is on our NHS weight loss injection page, and if you want to understand whether the weight loss injection is available on the NHS for your situation, that page covers the eligibility criteria in full, alongside a guide to how the weight loss injection NHS referral and approval process works in practice.